UiPath Inc. (NYSE:PATH) Receives Average Rating of “Hold” from Brokerages

Shares of UiPath Inc. (NYSE:PATH) have been given an average recommendation of “Hold” by the eighteen analysts that are presently covering the stock, MarketBeat reports. Sixteen equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $17.47.

Several research firms have commented on PATH. Barclays lifted their price target on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research note on Friday, September 6th. Needham & Company LLC reissued a “hold” rating on shares of UiPath in a research note on Wednesday, October 23rd. Morgan Stanley restated an “equal weight” rating and set a $15.00 target price on shares of UiPath in a report on Friday, September 6th. TD Cowen decreased their price target on UiPath from $17.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, September 6th. Finally, Bank of America raised their target price on shares of UiPath from $16.00 to $18.00 and gave the stock a “neutral” rating in a report on Friday, September 6th.

UiPath Stock Performance

Shares of NYSE:PATH opened at $12.76 on Wednesday. The firm has a fifty day moving average of $12.63 and a 200 day moving average of $13.25. UiPath has a 52-week low of $10.37 and a 52-week high of $27.87. The firm has a market capitalization of $7.01 billion, a PE ratio of -63.77 and a beta of 0.87.

UiPath (NYSE:PATH) last announced its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. The firm had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The company’s revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the company earned ($0.09) EPS. On average, sell-side analysts forecast that UiPath will post -0.23 EPS for the current fiscal year.

Insiders Place Their Bets

In other UiPath news, CFO Ashim Gupta sold 47,671 shares of UiPath stock in a transaction on Friday, September 13th. The stock was sold at an average price of $12.07, for a total transaction of $575,388.97. Following the completion of the transaction, the chief financial officer now owns 849,917 shares in the company, valued at approximately $10,258,498.19. The trade was a 5.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 22.37% of the company’s stock.

Hedge Funds Weigh In On UiPath

Several large investors have recently modified their holdings of the stock. Future Financial Wealth Managment LLC purchased a new stake in UiPath during the 3rd quarter valued at about $26,000. JTC Employer Solutions Trustee Ltd bought a new stake in shares of UiPath during the third quarter valued at approximately $26,000. Hantz Financial Services Inc. bought a new position in UiPath in the 2nd quarter valued at approximately $28,000. Quarry LP boosted its stake in UiPath by 654.4% during the 3rd quarter. Quarry LP now owns 3,146 shares of the healthcare company’s stock valued at $40,000 after purchasing an additional 2,729 shares during the last quarter. Finally, Redwood Wealth Management Group LLC purchased a new position in shares of UiPath in the second quarter worth $43,000. Hedge funds and other institutional investors own 62.50% of the company’s stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.